SEQUOIA GENETICS LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Summary
SEQUOIA GENETICS LTD is an active private limited company (company number 15646619) incorporated on 15 April 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2026, showing net assets of £288k and cash of £367k, with 18 employees on average. Net assets rose 2320% on the prior period (£12k).
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 15 April 20242 yrs ago
- Next accounts due
- 30 January 2028in 465 days
- Confirmation statement due
- 29 April 2027in 189 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- SIC 85590
- Other education n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2026 | £288k | £367k | £69k | £187k | — | — | 18 |
| 30 April 2025 | £12k | £364k | £87k | £454k | — | — | 11 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £287,683 at 30 April 2026
- Net assets up 10% or more on the prior period+2320.1% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.33
- Cash at bank of £50,000 or moreCash £366,632
- Incorporated two to five years agoIncorporated 15 April 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Ownership and control
- Dr Dipender Preet Singh Gill
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Next accounts duein 465 days
- Confirmation statement duein 189 days
- Accounts period endNet assets £288k · small accounts
- Accounts period endNet assets £12k · small accounts
- Incorporated
Similar companies in London
- INST OF CANCER POLICY LIMITEDLondon · inc. Apr 2024
- INVITROFLOW LTDLondon · inc. Apr 2024
- TRANSLATIONAL PATHOLOGY CONSULTING SERVICES LTDLondon · inc. Apr 2024
- OMNICARE DIAGNOSTICS LTDLondon · inc. Apr 2024
- OVARTIX LTDLondon · inc. Apr 2024
- COOPER WHYTE LIMITEDLondon · inc. Apr 2024
All companies incorporated on 15 April 2024 · in Apr 2024.
Reminders for SEQUOIA GENETICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.